(1)
Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With and Without Comorbid Allergic Rhinitis. J of Skin 2021, 5 (1), s13. https://doi.org/10.25251/skin.5.supp.13.